Roger Crystal, Chief Executive Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 20,847 shares at $17.04 ($358K) on 2018-10-09, disclosed to the SEC on 2018-10-10.
Open-market sale of $358k OPNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.14 | 847 | $15K | 4.3% |
| 2 | $17.33 | 3,059 | $53K | 14.8% |
| 3 | $17.33 | 3,059 | $53K | 14.8% |
| 4 | $17.04 | 6,941 | $118K | 33.0% |
| 5 | $17.04 | 6,941 | $118K | 33.0% |
| Total | $17.17 avg | 20,847 |
| $358K |
| 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |